esketamine
Understanding how ketamine helps the brain deal with depression
The promise of ketamine, an anesthetic drug primarily used at sub-anesthetic doses to either manage severe pain or send recreational ...
Ketamine for depression—what we know about how it changes the brain
The FDA's approval [of ketamine for depression] marks the first genuinely new type of psychiatric drug—for any condition—to be brought ...
Why esketamine will force doctors to rethink office visits for depressed patients
The Food and Drug Administration approved esketamine (Spravato) for treatment-resistant depression to be administered under physician supervision. It’s a derivative of ...
Viewpoint: Esketamine promises to boost depression treatments—but we don’t know enough about long-term effects
With great fanfare, a new antidepressant entered the U.S. market in March [2019], the first fundamentally new medicine for depression ...
Using ketamine for depression or recreation: What’s the difference?
[G]iven ketamine’s long-standing reputation as a recreational drug—so notorious that users talk about entering a “K-hole” after taking it—you might ...
Esketamine touted as ‘game changer’ for depression—but who gets to use it?
[Recently,] the Food and Drug Administration approved Johnson & Johnson’s Spravato, the nasal spray version of a ketamine-like sedative, for ...
Esketamine nasal spray, touted as biggest advance in years for treating depression, gets FDA approval
The Food and Drug Administration approved a novel antidepressant late Tuesday [March 5] for people with depression that does not ...
Esketamine could soon be approved for depression, prompting ‘excitement and hesitation’
The Food and Drug Administration is expected to decide in the coming weeks whether to approve esketamine, which would become the ...
